Primary biliary cirrhosis: Dashed hopes

Prescrire International

Volumn 11, Issue 59, 2002, Pages 67-69

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; CIPROFLOXACIN; COLESTYRAMINE; PLACEBO; URSODEOXYCHOLIC ACID;

ARTICLE; BRAIN DISEASE; CLINICAL STUDY; CLINICAL TRIAL; CYSTIC FIBROSIS; DIARRHEA; DRUG ABSORPTION; DRUG ANTAGONISM; DRUG CAPSULE; DRUG EFFECT; DRUG EFFICACY; ESOPHAGUS VARICES; EVIDENCE BASED MEDICINE; FOLLOW UP; GASTROINTESTINAL DISEASE; HISTOPATHOLOGY; HUMAN; HYDROPHILICITY; INTERSTITIAL PNEUMONIA; LIVER FAILURE; LIVER FIBROSIS; LIVER TRANSPLANTATION; LONG TERM CARE; META ANALYSIS; NAUSEA AND VOMITING; OSTEOMALACIA; PAIN; PRIMARY BILIARY CIRRHOSIS; RISK ASSESSMENT; SCLEROSING CHOLANGITIS; SYMPTOMATOLOGY; TABLET; TERATOGENICITY; VEIN RUPTURE;

EID: 0037940275     PISSN: 11677422     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Poupon RE et al. "Ursodiol for the long-term eatment of primary biliary cirrhosis" New Engl Med 1994; 330 (19): 1342-1347.
2. Prescrire Editorial Staff "Ursodeoxycholic acid" Prescr Int 1996; 5 (23): 80-82.
3. Goulis J et al. "Randomised controlled trials ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis" Lancet 1999; 354: 1053-1060.
4. Parés A et al. "Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of double-blind controlled multicentric trial" J Hepatol 2000; 32 (4): 561-566.
5. Lindor KD et al. "Effects of ursodeoxycholic acid on survival in patients with primary biliary Cirrhosis" Gastroenterology 1996; 110: 1515-1518.
6. Lindor KD et al. "Ursodeoxycholic acid in the treatment of primary biliary cirrhosis" Gastroenterology 1994; 106 (5): 1284-1290.
7. Combes B et al. "A randomized double-blind, placebo-controlled trial or ursodeoxycholic acid in primary biliary cirrhosis" Hepatology 1995; 22: 759-766.
8. Corpechot C et al. "The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis" Hepatology 2000; 32 (6): 1196-1199.
9. Lindor KD et al. "Ursodiol for primary sclerosing cholangitis" N Engl J Med 1997; 336 (10): 691-695.
10. Cheng K et al. "Ursodeoxycholic acid for cystic fibrosis-related liver disease" (Cochrane Review). In: "The Cochrane Library" Update Software, Oxford 2001; issue 1 (printout available: 15 pages).
11. "Ursodeoxycholic acid". In: "Martindale The Complete Drug Reference32nd ed, The Pharmaceutical Press, London 1999: 1642.
12. Vogel W et al. "Deterioration of primary biliary cirrhosis during treatment with ursodeoxycholic acid" Lancet 1988; 1: 1163.
13. Poupon R and Poupon RE Δeterioration in primary biliary cirrhosis in patient on ursodeoxycholic acid" Lancet 1988; 2: 166-167.
14. Pratt DS and Kaplan MM "Abdominal pain after taking ursodiol" N Engl J Med 1993; 328 (20): 1502.
15. "Ursodeoxycholic acid - Interstitial pneumonia" WHO Pharmaceuticals Newsletter 2000; (4): 14.
16. Bellieveau PP et al. "Reduction in serum concentrations of ciprofloxacin after administration of ursodiol to a patient with hepatobiliary disease" Clin Infect Dis 1994; 19: 354-355.
17. Combes B et al. "The effect of ursodeoxycholic acid on the florid duct lesion of primary biliary cirrhosis" Hepatology 1999; 30 (3): 602-605.
18. Angulo P et al. "Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial" J Hepatol 1999; 30 (5): 830-835.
19. Poupon RE et al. "Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis" Gastroenterology 1997; 113 (3): 884-890.
20. Lindor KD et al. "Ursodeoxycholic acid for primary biliary cirrhosis" Lancet 2000; 355: 657-658.